MARKETS / NASDAQ / ECOR
NASDAQ · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · SMALL CAP

electroCore, Inc. ECOR

9 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$32.0M
▲ 27.2% vs FY2024
EPS · FY25
$-1.65
Dividend / sh · FY25
Payout · FY25
ROE · FY25
-478.7%
Net margin · FY25
-43.6%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 32.0M
Revenue, FY2025 · full 9-year series below
Revenue Net income
0.010.020.030.040.0-0.02017202020232025
0.010.020.030.040.0-0.02017202020232025

The company lost 44 cents on every revenue dollar this year.

Per share
USD -1.65
Diluted EPS, FY2025
EPS
0.40.81.2-1.652017202020232025
0.40.81.2-1.652017202020232025

The company pays no cash dividend.

Profitability
-478.7%
Return on equity, FY2025
ROE
0.250.50.751-478.7%2017202020232025
0.250.50.751-478.7%2017202020232025
Operating margin-41.1%
Net margin-43.6%
Return on assets-71.4%

Each USD of equity lost 479 cents this year.

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacks
Share of profit
Consecutive raises

Growth
+55.7% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+55.1%
+55.7%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.01B
Shares outstanding, FY2025
0.000.012017202020232025
0.000.012017202020232025
Change, 5 years
Change, 10 years

A share split breaks the comparison across the period, so we leave it out.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 18.7M
total assets, end of FY2025
Total assetsUSD 18.7M
EquityUSD -1.7M
CashUSD 7.0M
Gross debtUSD 6.6M
Net debtUSD -428,000.00
Current ratio1.38×

The company holds more cash than debt.

History
9 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.1
−0.0
EBITDA $B
·
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.1
−0.0
Income tax $B
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
0.0
·
Net income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.1
−0.0
EPS, diluted $
−1.65
−1.59
−3.42
−4.69
−4.36
−0.60
−1.54
−1.19
·
Dividend / sh $
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
ROE %
−478.7
−158.6
−153.6
−82.5
−57.7
−99.5
−100.5
·
·
Shares out B
0.01
0.01
0.01
0.00
0.00
0.05
0.03
0.03
0.00

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
34 of 35
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 1 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed